NCT02611817 Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT02597829 Does Clinical Response Correlate With Serum Certolizumab Levels? Status UNKNOWN Phase PHASE4
NCT02580617 A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease Status UNKNOWN Phase PHASE1
NCT02578576 The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease Status UNKNOWN Phase N/A
NCT02574637 Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT02559713 Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease Status COMPLETED Phase PHASE4
NCT02550158 A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT02549976 Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis Status COMPLETED Phase NA
NCT02542917 Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study Status COMPLETED Phase N/A
NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02538679 A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques Status COMPLETED Phase NA
NCT02538341 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Status COMPLETED Phase PHASE2
NCT02531113 Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT02508012 Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort Status COMPLETED Phase N/A